Brief: Exscientia Announces AI Drug Discovery Collaboration With Merck KGaA, Darmstadt, Germany
Sept 20 (Reuters) - Exscientia PLC EXAI.O :
* EXSCIENTIA ANNOUNCES AI DRUG DISCOVERY COLLABORATION WITH
MERCK
KGAA, DARMSTADT, GERMANY
* EXSCIENTIA - EXSCIENTIA IS ELIGIBLE TO RECEIVE UP TO $674
MILLION IN DISCOVERY, DEVELOPMENT, REGULATORY AND SALES-BASED
MILESTONES FOR THREE PROJECTS
* EXSCIENTIA - EXSCIENTIA WILL RECEIVE AN UPFRONT CASH
PAYMENT OF
$20 MILLION FROM MERCK KGAA
Source text for Eikon: ID:nBw3Twbp0a
Further company coverage: EXAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Exscientia
See all newsExscientia PLC expected to post a loss of 9 cents a share - Earnings Preview
Brief: Exscientia Achieves Milestones For Two Programmes In Sanofi Collaboration
Exscientia PLC reports results for the quarter ended in June - Earnings Summary
Deals of the day-Mergers and acquisitions
Biotech firm Recursion to buy smaller peer Exscientia for $688 million